Select for export The Effect of 5-HT2A/1a Agonist Treatment On Social Cognition, Empathy, and Social Decision-making Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s0924-9338(15)30017-1 Copy citation Copy BibTeX European Psychiatry 2015-02-28 Katrin H. Preller, Thomas Pokorny, Rainer Krähenmann, I. Dziobek, Philipp Stämpfli, F.X. Vollenweider OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/2045125314527985 PubMed 25083275 Copy citation Copy BibTeX Therapeutic advances in psychopharmacology 2014-07-31 Baumeister D, Barnes G, Giaroli G, Tracy D PubMed Published psilocybin DepressionAnxietyPharmacology Clinical Trial More
Select for export Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.biopsych.2014.04.010 PubMed 24882567 Copy citation Copy BibTeX Biological Psychiatry 2014-04-25 Kraehenmann R, Preller KH, Scheidegger M, Pokorny T, Bosch OG, Seifritz E Europe PMC Published psilocybin DepressionAnxietyBrain Imaging Clinical Trial More
Select for export Psychopathological effects of S-ketamine and dimethyltryptamine (DMT) in humans: a double-blind, cross-over human experimental study of the NMDA antagonist and the 5HT2A agonist model of psychosis Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/s-2005-918695 Copy citation Copy BibTeX Pharmacopsychiatry 2005-08-31 Euphrosyne Gouzoulis-Mayfrank, Anna Neukirch, Karsten Heekeren OpenAlex Published psilocybin DepressionPharmacologyReceptor Pharmacology Other More
Select for export P.6.057 Effects of 2A receptor challenge by psilocybin on cognitive performance and neuroendocrine measures in healthy humans: A serotonin model of psychosis No abstract availability was recorded for this entry. Details DOI 10.1016/s0924-977x(03)92355-8 Copy citation Copy BibTeX European Neuropsychopharmacology 2003-09-30 Felix Hasler, Ulrike Grimberg, Martin Benz, F.X. Vollenweider OpenAlex Published psilocybin DepressionAddictionPharmacology Other More
